Suchergebnisse - "Guan, Xiuwen"

PubPharm (7)

1

Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer

enthalten in: Signal transduction and targeted therapy | 2023

von Guan, X. | Ma, F. | Li, Q. | +7

2

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

enthalten in: International journal of cancer | 2020

von Ma, F. | Guan, Y. | Yi, Z. | +16

ErratumIn: Int J Cancer. 2020 Jun 15;146(12):E8. - PMID 32320496

3

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

4

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Cancer communications | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

5

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Chinese journal of cancer | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

6

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients : A Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, Q. | Guan, X. | Chen, S. | +16

7

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Guan, X. | Ma, F. | Li, C. | +13

1
[1]